FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roberto Lemoli

Research Profile

Anatomy

Chemicals & Drugs

Procedures

Disorders

Physiology

Co-author Network

Publications

TOP 3
Marilena Ciciarello; Davide Ferrari; Rossella Manfredini; Lara Rossi; Valentina Salvestrini; Roberta Zini; Roberto M Lemoli
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.
Lara Rossi; Roberto M Lemoli; Margaret A Goodell
Gpr171, a putative P2Y-like receptor, negatively regulates myeloid differentiation in murine hematopoietic progenitors.
Lara Rossi; Valentina Salvestrini; Francesco Di Virgilio; Davide Ferrari; Roberto M Lemoli
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roberto Lemoli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marilena Ciciarello; Davide Ferrari; Rossella Manfredini; Lara Rossi; Valentina Salvestrini; Roberta Zini; Roberto M Lemoli
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.
Stem cells and development 2013;22(7):1097-111.
2013: Lara Rossi; Roberto M Lemoli; Margaret A Goodell
Gpr171, a putative P2Y-like receptor, negatively regulates myeloid differentiation in murine hematopoietic progenitors.
Experimental hematology 2013;41(1):102-12.
2012: Lara Rossi; Valentina Salvestrini; Francesco Di Virgilio; Davide Ferrari; Roberto M Lemoli
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling.
Blood 2012;120(12):2365-75.
2012: Sara Trabanelli; Rodolfo de Paula Vieira; Darina Ocadlíková; Valentina Salvestrini; Antonio Curti; Francesco Di Virgilio; Davide Ferrari; Sara Gulinelli; Marco Idzko; Roberto M Lemoli
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(3):1303-10.
2012: Esa Jantunen; Roberto M Lemoli
Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept.
Transfusion 2012;52(4):906-14.
2012: Roberto M Lemoli
New strategies for stem cell mobilization.
Mediterranean journal of hematology and infectious diseases 2012;4(1):e2012066.
2011: Antonio Curti; Alessandra D'Addio; Elisa Dan; F Fruet; Valeria Giudice; Alessandro Isidori; Michele Baccarani; Giuseppe Bandini; Andrea Bontadini; Giovanni Martinelli; Maria Rosa Motta; Stefania Paolini; Sarah Parisi; Loredana Ruggeri; Sara Trabanelli; Elena Urbani; Andrea Velardi; Roberto M Lemoli
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
Blood 2011;118(12):3273-9.
2011: Lucia Catani; Daria Sollazzo; Francesca Ricci; Nicola Polverelli; Francesca Palandri; Michele Baccarani; Nicola Vianelli; Roberto M Lemoli
The CD47 pathway is deregulated in human immune thrombocytopenia.
Experimental hematology 2011;39(4):486-94.
2011: Davide Ferrari; Sara Gulinelli; Valentina Salvestrini; Giovanna Lucchetti; Roberta Zini; Rossella Manfredini; Luisa Caione; Wanda Piacibello; Marilena Ciciarello; Lara Rossi; Marco Idzko; Sergio Ferrari; Francesco Di Virgilio; Roberto M Lemoli
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines.
Experimental hematology 2011;39(3):360-74, 374.e1-5.
2011: A D'Addio; Antonio Curti; N Worel; K Douglas; M R Motta; S Rizzi; E Dan; Simona Taioli; V Giudice; H Agis; G Kopetzky; R Soutar; B Casadei; Michele Baccarani; Roberto M Lemoli
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.
Bone marrow transplantation 2011;46(3):356-63.
2011: Roberto M Lemoli; Alessandra D'Addio
Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
Revista brasileira de hematologia e hemoterapia 2011;33(3):172-3.
2010: Antonio Curti; Sara Trabanelli; Chiara Onofri; Michela Aluigi; Valentina Salvestrini; Darina Ocadlikova; Cecilia Evangelisti; Sergio Rutella; Raimondo De Cristofaro; Emanuela Ottaviani; Michele Baccarani; Roberto M Lemoli
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Haematologica 2010;95(12):2022-30.
2010: Roberto M Lemoli; Alessandra D'Addio; G Marotta; L Pezzullo; Elisa Zuffa; Mauro Montanari; Antonio de Vivo; Alessandro Bonini; Piero Galieni; A M Carella; S Guidi; Mariagrazia Michieli; Attilio Olivieri; A Bosi
BU/melphalan and auto-SCT in AML patients in first CR: a 'Gruppo Italiano Trapianto di Midollo Osseo (GITMO)' retrospective study.
Bone marrow transplantation 2010;45(4):640-6.
2009: Roberto M Lemoli; Valentina Salvestrini; Elisa Bianchi; Francesco Bertolini; Miriam Fogli; Marilina Amabile; Agostino Tafuri; Simona Salati; Roberta Zini; Nicoletta Testoni; Cristina Rabascio; Lara Rossi; Ines Martin-Padura; Fausto Castagnetti; Paola Marighetti; Giovanni Martinelli; Michele Baccarani; Sergio Ferrari; Rossella Manfredini
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.
Blood 2009;114(25):5191-200.
2009: Marco Domenicali; Paolo Caraceni; Ferdinando Giannone; Maurizio Baldassarre; Giovanna Lucchetti; Carmelo Quarta; Corrado Patti; Lucia Catani; Cristina Nanni; Roberto M Lemoli; Mauro Bernardi
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
Journal of hepatology 2009;51(6):991-9.
2009: Lucia Catani; Roberta Zini; D Sollazzo; Emanuela Ottaviani; Alessandro M Vannucchi; Sergio Ferrari; Michele Baccarani; Nicola Vianelli; Roberto M Lemoli; Rossella Manfredini
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia.
Leukemia 2009;23(5):997-1000.
2009: Antonio Curti; Sara Trabanelli; Valentina Salvestrini; Michele Baccarani; Roberto M Lemoli
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology.
Blood 2009;113(11):2394-401.
2008: Stefania Lorenzini; Alessandro Isidori; Lucia Catani; Annagiulia Gramenzi; Simona Talarico; Francesca Bonifazi; Valeria Giudice; Roberto Conte; Michele Baccarani; Mauro Bernardi; S J Forbes; Roberto M Lemoli; Pietro Andreone
Stem cell mobilization and collection in patients with liver cirrhosis.
Alimentary pharmacology & therapeutics 2008;27(10):932-9.
2008: Antonio Curti; Sara Trabanelli; Roberto M Lemoli
More ADO about IDO: GVHD.
Blood 2008;111(6):2950.
2008: Roberto M Lemoli; Alessandra D'Addio
Hematopoietic stem cell mobilization.
Haematologica 2008;93(3):321-4.
2007: Antonio Curti; Patrizia Tosi; Patrizia Comoli; Carolina Terragna; Elisa Ferri; Claudia Cellini; Massimo Massaia; Alessandra D'Addio; Valeria Giudice; Cristiana Di Bello; Michele Cavo; Roberto Conte; Gabriele Gugliotta; Michele Baccarani; Roberto M Lemoli
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
British journal of haematology 2007;139(3):415-24.
2007: Alessandro Isidori; Maria Rosa Motta; Monica Tani; Carolina Terragna; Pier Luigi Zinzani; Antonio Curti; Simonetta Rizzi; Simona Taioli; Valeria Giudice; Alessandra D'Addio; Gabriele Gugliotta; Roberto Conte; Michele Baccarani; Roberto M Lemoli
Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1224-32.
2007: Paolo Caraceni; F Giannone; Lucia Catani; Simona Talarico; Anna Maria Pertosa; Marco Domenicali; Miriam Fogli; Alfonso Principe; Franco Trevisani; Michele Baccarani; Mauro Bernardi; Roberto M Lemoli
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2007;39(10):943-51.
2007: Antonio Curti; Simona Pandolfi; Barbara Valzasina; Michela Aluigi; Alessandro Isidori; Elisa Ferri; Valentina Salvestrini; Giuseppina Bonanno; Sergio Rutella; Ilaria Durelli; Alberto L Horenstein; Francesca Fiore; Massimo Massaia; Mario P Colombo; Michele Baccarani; Roberto M Lemoli
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.
Blood 2007;109(7):2871-7.
2007: Antonio Curti; Michela Aluigi; Simona Pandolfi; Elisa Ferri; Alessandro Isidori; Valentina Salvestrini; Ilaria Durelli; Alberto L Horenstein; Francesca Fiore; Massimo Massaia; M Piccioli; S A Pileri; E Zavatto; Alessandra D'Addio; Michele Baccarani; Roberto M Lemoli
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.
Leukemia 2007;21(2):353-5.
2007: Lara Rossi; Rossella Manfredini; Francesco Bertolini; Davide Ferrari; Miriam Fogli; Roberta Zini; Simona Salati; Valentina Salvestrini; Sara Gulinelli; Elena Adinolfi; Sergio Ferrari; Francesco Di Virgilio; Michele Baccarani; Roberto M Lemoli
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration.
Blood 2007;109(2):533-42.
2006: Roberto M Lemoli; Lucia Catani; Simona Talarico; Elisabetta Loggi; Annagiulia Gramenzi; Umberto Baccarani; Miriam Fogli; Gian Luca Grazi; Michela Aluigi; Giulia Marzocchi; Mauro Bernardi; Antonio Pinna; Fabrizio Bresadola; Michele Baccarani; Pietro Andreone
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.
Stem cells (Dayton, Ohio) 2006;24(12):2817-25.
2006: Roberto M Lemoli
Zoledronic acid modulates function and differentiation of myeloid cells.
Haematologica 2006;91(9):1153A.
2006: Lucia Catani; Maria Elena Fagioli; Pier Luigi Tazzari; Francesca Ricci; Antonio Curti; Manuela Rovito; Paola Preda; Gabriella Chirumbolo; Marilina Amabile; Roberto M Lemoli; Sante Tura; Roberto Conte; Michele Baccarani; Nicola Vianelli
Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
Experimental hematology 2006;34(7):879-87.
2006: Sergio Rutella; Giuseppina Bonanno; Annabella Procoli; Andrea Mariotti; Daniela G De Ritis; Antonio Curti; Silvio Danese; Gloria Pessina; Simona Pandolfi; Federica Natoni; Annalaura Di Febo; Giovanni Scambia; Rossella Manfredini; Simona Salati; Sergio Ferrari; Luca Pierelli; Giuseppe Leone; Roberto M Lemoli
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features.
Blood 2006;108(1):218-27.
2006: Davide Ferrari; Cinzia Pizzirani; Elena Adinolfi; Roberto M Lemoli; Antonio Curti; Marco Idzko; Elisabeth Panther; Francesco Di Virgilio
The P2X7 receptor: a key player in IL-1 processing and release.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(7):3877-83.
2006: Michela Aluigi; Miriam Fogli; Antonio Curti; Alessandro Isidori; Elisa Gruppioni; Claudia Chiodoni; Mario P Colombo; Piera Versura; Antonia D'Errico-Grigioni; Elisa Ferri; Michele Baccarani; Roberto M Lemoli
Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells.
Stem cells (Dayton, Ohio) 2006;24(2):454-61.
2005: Antonio Curti; Simona Pandolfi; Michela Aluigi; Alessandro Isidori; Isabella Alessandrini; Claudia Chiodoni; Nicoletta Testoni; Mario P Colombo; Michele Baccarani; Roberto M Lemoli
Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Experimental hematology 2005;33(12):1521-30.
2005: Roberto M Lemoli
Pegfilgrastim for mobilization of stem cells in allogeneic donors.
Haematologica 2005;90(12):1590A.
2005: Rossella Manfredini; Roberta Zini; Simona Salati; Michela Siena; Elena Tenedini; Enrico Tagliafico; Monica Montanari; Tommaso Zanocco-Marani; Claudia Gemelli; Tatiana Vignudelli; Alexis Grande; Miriam Fogli; Lara Rossi; Maria Elena Fagioli; Lucia Catani; Roberto M Lemoli; Sergio Ferrari
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment.
Stem cells (Dayton, Ohio) 2005;23(4):496-506.
2005: Roberto M Lemoli; Francesco Bertolini; Ranieri Cancedda; Michele De Luca; Antonio Del Santo; Giuliana Ferrari; Sergio Ferrari; Gianvito Martino; Fulvio Mavilio; Sante Tura
Stem cell plasticity: time for a reappraisal?
Haematologica 2005;90(3):360-81.
2005: Alessandro Isidori; Monica Tani; Francesca Bonifazi; Pier Luigi Zinzani; Antonio Curti; Maria Rosa Motta; Simonetta Rizzi; Valeria Giudice; Oriana Farese; Manuela Rovito; Lapo Alinari; Roberto Conte; Michele Baccarani; Roberto M Lemoli
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
Haematologica 2005;90(2):225-31.
2005: Stefania Varani; Giada Frascaroli; Davide Gibellini; Luciano Potena; Tiziana Lazzarotto; Roberto M Lemoli; Carlo Magelli; Cecilia Söderberg-Naucler; Maria P Landini
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection.
Transplantation 2005;79(2):219-27.
2005: Alessandro Isidori; Francesca Bonifazi; Giuseppe Visani; Filippo Gherlinzoni; Michele Baccarani; Roberto M Lemoli
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients.
Haematologica 2005;90(1):139-41.
2004: Roberto M Lemoli; Davide Ferrari; Miriam Fogli; Lara Rossi; Cinzia Pizzirani; Sylvia Forchap; Paola Chiozzi; Diletta Vaselli; Francesco Bertolini; Thomas Foutz; Michela Aluigi; Michele Baccarani; Francesco Di Virgilio
Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo.
Blood 2004;104(6):1662-70.
2004: Antonio Curti; Alessandro Isidori; Elisa Ferri; Carolina Terragna; Paolo Neyroz; Claudia Cellini; Marina Ratta; Michele Baccarani; Roberto M Lemoli
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
Leukemia & lymphoma 2004;45(7):1419-28.
2004: Sergio Rutella; Roberto M Lemoli
Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.
Immunology letters 2004;94(1-2):11-26.
2004: Sergio Rutella; Giuseppina Bonanno; Luca Pierelli; Andrea Mariotti; Ettore Capoluongo; Anna Maria Contemi; Franco Ameglio; Antonio Curti; Daniela G De Ritis; Maria Teresa Voso; Alessandro Perillo; Salvatore Mancuso; Giovanni Scambia; Roberto M Lemoli; Giuseppe Leone
Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha.
European journal of immunology 2004;34(5):1291-302.
2004: Pier Luigi Zinzani; Monica Tani; Annalisa Gabriele; Filippo Gherlinzoni; Antonio de Vivo; Paolo Ricci; Giuseppe Bandini; Roberto M Lemoli; Maria Rosa Motta; Simonetta Rizzi; Valeria Guidice; Maurizio Zompatori; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Enrica Marchi; Simona Bassi; Roberto Conte; Stefano Pileri; Sante Tura; Michele Baccarani
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience.
Leukemia & lymphoma 2004;45(2):321-6.
2004: Antonio Curti; Elisa Ferri; Simona Pandolfi; Alessandro Isidori; Roberto M Lemoli
Dendritic cell differentiation.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(1):3; author reply 3-4.
2003: Roberto M Lemoli; Francesco Bertolini; Maria Teresa Petrucci; Chiara Gregorj; Maria R Ricciardi; Miriam Fogli; Antonio Curti; Cristina Rabascio; Simona Pandolfi; Sergio Ferrari; Robin Foá; Michele Baccarani; Agostino Tafuri; Cristina Rabascio; Robin Fo
Functional and kinetic characterization of granulocyte colony-stimulating factor-primed CD34- human stem cells.
British journal of haematology 2003;123(4):720-9.
2003: Roberto M Lemoli; Antonio de Vivo; Daniela Damiani; Alessandro Isidori; Monica Tani; Alessandro Bonini; Claudia Cellini; Antonio Curti; Luigi Gugliotta; Giuseppe Visani; Renato Fanin; Michele Baccarani
Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization.
Blood 2003;102(5):1595-600.
2003: Pier Luigi Zinzani; Monica Tani; Annalisa Gabriele; Filippo Gherlinzoni; Antonio de Vivo; Paolo Ricci; Giuseppe Bandini; Roberto M Lemoli; Maria Rosa Motta; Simonetta Rizzi; Valeria Giudice; Maurizio Zompatori; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Simona Bassi; Roberto Conte; Stefano Pileri; Sante Tura; Michele Baccarani
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience.
Haematologica 2003;88(5):522-8.
2003: Maria Rosa Motta; Samantha Castellani; Simonetta Rizzi; Antonio Curti; Francesco Gubinelli; Miriam Fogli; Elisa Ferri; Claudia Cellini; Michele Baccarani; Roberto M Lemoli
Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination.
British journal of haematology 2003;121(2):240-50.
2002: Roberto M Lemoli; Antonio Curti; Miriam Fogli; Elisa Ferri; Michele Baccarani
The therapeutic role of dendritic cells in cancer immunotherapy.
Haematologica 2002;87(8 Suppl):62-6.
2002: Antonio Curti; Mario P Colombo; M Baccarani; Roberto M Lemoli
Transduction of MHC-class I negative allogeneic cell line to improve the efficacy of anti-tumor vaccination.
Journal of biological regulators and homeostatic agents 2002;16(3):236-40.
2002: Marina Ratta; Francesco F Fagnoni; Antonio Curti; Rosanna Vescovini; Paolo Sansoni; Barbara Oliviero; Miriam Fogli; Elisa Ferri; Gioacchino Robustelli Della Cuna; Sante Tura; Michele Baccarani; Roberto M Lemoli
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.
Blood 2002;100(1):230-7.
2002: Antonio Curti; Agostino Tafuri; Maria R Ricciardi; Pier Luigi Tazzari; Maria Teresa Petrucci; Miriam Fogli; Marina Ratta; Rosa Lapalombella; Elisa Ferri; Sante Tura; Michele Baccarani; Roberto M Lemoli
Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1).
Haematologica 2002;87(4):373-80.
2001: Pier Luigi Tazzari; Letizia Polito; Andrea Bolognesi; Maria Pia Pistillo; Paolo Capanni; Giulio L Palmisano; Roberto M Lemoli; A Curti; L Biancone; G Camussi; Roberto Conte; Giovanni Battista Ferrara; Fiorenzo Stirpe
Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(8):4222-9.
2001: Nicola Vianelli; L Valdrè; Mauro Fiacchini; Antonio de Vivo; Luigi Gugliotta; Lucia Catani; Roberto M Lemoli; M Poli; Sante Tura
Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients.
Haematologica 2001;86(5):504-9.
2001: Maria R Ricciardi; Maria Teresa Petrucci; Chiara Gregorj; Cristina Ariola; Roberto M Lemoli; Miriam Fogli; Francesca Romana Mauro; Raffaella Cerretti; Robin Foà; Franco Mandelli; Agostino Tafuri
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia.
British journal of haematology 2001;113(2):391-9.
2001: Antonio Curti; Marina Ratta; S Corinti; Giampiero Girolomoni; Francesca Ricci; Pier Luigi Tazzari; Michela Siena; Alexis Grande; Miriam Fogli; Sante Tura; Roberto M Lemoli
Interleukin-11 induces Th2 polarization of human CD4(+) T cells.
Blood 2001;97(9):2758-63.
2001: Giuseppe Visani; Roberto M Lemoli; Alessandro Isidori; Pier Paolo Piccaluga; giovanni martinelli; Michele Malagola; Luigi Gugliotta; Alessandro Bonini; Francesca Bonifazi; Maria Rosa Motta; Simonetta Rizzi; Samantha Castellani; Sante Tura
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients.
Bone marrow transplantation 2001;27(8):829-35.
2001: Antonio Curti; Miriam Fogli; Marina Ratta; Sante Tura; Roberto M Lemoli
Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(2):848-54.
2001: Antonio Curti; Miriam Fogli; Marina Ratta; G Biasco; Sante Tura; Roberto M Lemoli
Dendritic cell differentiation from hematopoietic CD34+ progenitor cells.
Journal of biological regulators and homeostatic agents 2001;15(1):49-52.
2000: Maria Teresa Petrucci; Maria R Ricciardi; Chiara Gregorj; Cristina Ariola; F Mazzola; Miriam Fogli; Roberto M Lemoli; Agostino Tafuri
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells.
Leukemia & lymphoma 2000;40(1-2):179-90.
2000: Monica Bocchia; V Bronte; M P Colombo; A de Vincentiis; M Di Nicola; G Forni; L Lanata; Roberto M Lemoli; Massimo Massaia; Damiano Rondelli; P Zanon; Sante Tura
Antitumor vaccination: where we stand.
Haematologica 2000;85(11):1172-206.
2000: Cristina Tassi; Pier Luigi Tazzari; Roberto M Lemoli; Francesca Ricci; Sante Tura; Roberto Conte
Kinetics variation of CD34+ and CD34+CD90+ in subjects following different mobilizing protocols.
Haematologica 2000;85(10):1118-20.
2000: giovanni martinelli; Carolina Terragna; Elena Zamagni; Sonia Ronconi; Patrizia Tosi; Roberto M Lemoli; Giuseppe Bandini; Nicoletta Testoni; Marilina Amabile; Emanuela Ottaviani; Silvia Buonamici; Simona Soverini; Vittorio Montefusco; Antonio de Vivo; Francesca Bonifazi; Sante Tura; Michele Cavo
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation.
Haematologica 2000;85(9):930-4.
2000: giovanni martinelli; Vittorio Montefusco; Marilina Amabile; Roberto M Lemoli; Carolina Terragna; Nicoletta Testoni; Emanuela Ottaviani; Gianantonio Rosti; Antonio de Vivo; Simonetta Rizzi; Domenico Russo; M Bregoli; Sante Tura
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response.
Leukemia & lymphoma 2000;39(1-2):113-20.
2000: Marina Ratta; Antonio Curti; Miriam Fogli; M Pantucci; G Viscomi; Pier Luigi Tazzari; Francesco F Fagnoni; Rosanna Vescovini; Paolo Sansoni; Sante Tura; Roberto M Lemoli
Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Experimental hematology 2000;28(8):931-40.
2000: Andrea Bolognesi; Letizia Polito; Pier Luigi Tazzari; Roberto M Lemoli; Chiara Lubelli; Miriam Fogli; Louis Boon; Mark de Boer; Fiorenzo Stirpe
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins.
British journal of haematology 2000;110(2):351-61.
2000: Miriam Fogli; Carmelo Carlo-Stella; Antonio Curti; Marina Ratta; Pier Luigi Tazzari; E Ragazzi; Simona Colla; A M Santucci; Sante Tura; Roberto M Lemoli
Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis.
Experimental hematology 2000;28(7):775-83.
2000: Michele Cavo; Carolina Terragna; giovanni martinelli; Sonia Ronconi; Elena Zamagni; Patrizia Tosi; Roberto M Lemoli; Monica Benni; G Pagliani; Giuseppe Bandini; Sante Tura
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma.
Blood 2000;96(1):355-7.
2000: giovanni martinelli; Carolina Terragna; Elena Zamagni; Sonia Ronconi; Patrizia Tosi; Roberto M Lemoli; Giuseppe Bandini; Maria Rosa Motta; Nicoletta Testoni; Marilina Amabile; Emanuela Ottaviani; Nicola Vianelli; Antonio de Vivo; Alessandro Gozzetti; Sante Tura; Michele Cavo
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2273-81.
2000: Roberto M Lemoli; giovanni martinelli; Elena Zamagni; Maria Rosa Motta; Simonetta Rizzi; Carolina Terragna; Roberto Rondelli; Sonia Ronconi; Antonio Curti; Francesca Bonifazi; Sante Tura; Michele Cavo
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy.
Blood 2000;95(7):2234-9.
1999: Lucia Catani; Nicola Vianelli; Simona Luatti; Simonetta Rizzi; Samantha Castellani; L Valdrè; Roberto M Lemoli; Sante Tura
Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets.
Bone marrow transplantation 1999;24(11):1191-4.
1999: C Bordignon; Carmelo Carlo-Stella; M P Colombo; A de Vincentiis; L Lanata; Roberto M Lemoli; Franco Locatelli; A Olivieri; Damiano Rondelli; P Zanon; Sante Tura
Cell therapy: achievements and perspectives.
Haematologica 1999;84(12):1110-49.
1999: Roberto M Lemoli; giovanni martinelli; Attilio Olivieri; Maria Rosa Motta; Simonetta Rizzi; Carolina Terragna; Giuliana Leopardi; Monica Benni; Sonia Ronconi; I Cantori; Damiano Rondelli; S Mangianti; Pietro Leoni; Mauro Montanari; Michele Cavo; Sante Tura
Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study.
British journal of haematology 1999;107(2):419-28.
1999: Damiano Rondelli; Roberto M Lemoli; Marina Ratta; Miriam Fogli; Francesca Re; Antonio Curti; Mario Arpinati; Sante Tura
Rapid induction of CD40 on a subset of granulocyte colony-stimulating factor-mobilized CD34(+) blood cells identifies myeloid committed progenitors and permits selection of nonimmunogenic CD40(-) progenitor cells.
Blood 1999;94(7):2293-300.
1999: Giuseppe Visani; Roberto M Lemoli; Patrizia Tosi; giovanni martinelli; Nicoletta Testoni; Paolo Ricci; M Motta; Filippo Gherlinzoni; Giuliana Leopardi; R Pastano; Simonetta Rizzi; Pier Paolo Piccaluga; Alessandro Isidori; Sante Tura
Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Bone marrow transplantation 1999;24(5):467-72.
1999: Rossella Manfredini; F Trevisan; Alexis Grande; Enrico Tagliafico; Monica Montanari; Roberto M Lemoli; G Visani; Sante Tura; Sergio Ferrari; S Ferrari
Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Cancer research 1999;59(15):3803-11.
1999: Agostino Tafuri; Roberto M Lemoli; Maria Teresa Petrucci; Maria R Ricciardi; Miriam Fogli; Laura Bonsi; Cristina Ariola; Pierluigi Strippoli; Chiara Gregorj; Maria Concetta Petti; Sante Tura; Franco Mandelli; Gian Paolo Bagnara
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells.
Experimental hematology 1999;27(8):1255-63.
1999: Giuseppe Visani; Roberto M Lemoli; Patrizia Tosi; giovanni martinelli; Nicoletta Testoni; Paolo Ricci; Pier Paolo Piccaluga; R Pastano; Giuliana Leopardi; A Dizdari; Maria Rosa Motta; Simonetta Rizzi; Sante Tura
Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients.
British journal of haematology 1999;105(3):775-9.
1999: giovanni martinelli; Carolina Terragna; Roberto M Lemoli; Michele Cavo; Monica Benni; Maria Rosa Motta; Marilina Amabile; Emanuela Ottaviani; Nicoletta Testoni; Antonio de Vivo; Sante Tura
Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells.
Haematologica 1999;84(5):397-404.
1999: Roberto M Lemoli; Antonio Curti; Sante Tura
Negative selection of autologous peripheral blood stem cells.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):57-69.
1999: Roberto M Lemoli; Giuseppe Visani; Giuliana Leopardi; Maria Rosa Motta; Simonetta Rizzi; Nicoletta Testoni; Antonio Curti; Sante Tura
Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Bone marrow transplantation 1999;23(3):235-41.
1998: Roberto M Lemoli; Agostino Tafuri; A Fortuna; Lucia Catani; Damiano Rondelli; Marina Ratta; Sante Tura
Biological characterization of CD34+ cells mobilized into peripheral blood.
Bone marrow transplantation 1998;22 Suppl 5():S47-50.
1998: Nicoletta Testoni; Roberto M Lemoli; giovanni martinelli; C Carboni; S Pelliconi; Emanuela Ottaviani; Deborah Ruggeri; Simonetta Rizzi; Maria Rosa Motta; Giuseppe Visani; Sante Tura
Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods.
Bone marrow transplantation 1998;22(11):1065-70.
1998: Damiano Rondelli; Donatella Raspadori; C Anasetti; Giuseppe Bandini; Francesca Re; Mario Arpinati; Marta Stanzani; A Morelli; Cesare Baccini; Alfonso Zaccaria; Roberto M Lemoli; Sante Tura
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells.
Bone marrow transplantation 1998;22(7):631-7.
1998: Massimo Aglietta; F Bertolini; Carmelo Carlo-Stella; A de Vincentiis; L Lanata; Roberto M Lemoli; A Olivieri; Salvatore Siena; P Zanon; Sante Tura
Ex vivo expansion of hematopoietic cells and their clinical use.
Haematologica 1998;83(9):824-48.
1998: Michele Cavo; Giuseppe Bandini; Monica Benni; Alessandro Gozzetti; Sonia Ronconi; Gianantonio Rosti; Elena Zamagni; Roberto M Lemoli; Alessandro Bonini; A Belardinelli; Maria Rosa Motta; Simonetta Rizzi; Sante Tura
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma.
Bone marrow transplantation 1998;22(1):27-32.
1998: Damiano Rondelli; C Anasetti; A Fortuna; Marina Ratta; Mario Arpinati; Giuseppe Bandini; Roberto M Lemoli; Sante Tura
T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells.
Bone marrow transplantation 1998;21(12):1183-91.
1998: Marina Ratta; Damiano Rondelli; A Fortuna; Antonio Curti; Miriam Fogli; Francesco F Fagnoni; giovanni martinelli; Carolina Terragna; Sante Tura; Roberto M Lemoli
Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells.
British journal of haematology 1998;101(4):756-65.
1998: Andrea Bolognesi; Pier Luigi Tazzari; F Olivieri; Letizia Polito; Roberto M Lemoli; Adelmo Terenzi; Laura Pasqualucci; Brunangelo Falini; Fiorenzo Stirpe
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies.
British journal of haematology 1998;101(1):179-88.
1998: Miriam Fogli; Marilina Amabile; giovanni martinelli; A Fortuna; Damiano Rondelli; Marina Ratta; Antonio Curti; Sante Tura; Roberto M Lemoli
Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow.
British journal of haematology 1998;101(1):119-29.
1998: William Arcese; F Aversa; Giuseppe Bandini; A de Vincentiis; Michele Falda; L Lanata; Roberto M Lemoli; Franco Locatelli; Ignazio Majolino; P Zanon; Sante Tura
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow.
Haematologica 1998;83(2):159-82.
1998: Roberto M Lemoli; Giuseppe Bandini; Giuliana Leopardi; Gianantonio Rosti; Alessandro Bonini; A Fortuna; Damiano Rondelli; S Mangianti; Maria Rosa Motta; Simonetta Rizzi; Cristina Tassi; Michele Cavo; C Remiddi; Antonio Curti; Roberto Conte; Sante Tura
Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Haematologica 1998;83(1):48-55.
1998: Lucia Catani; Luigi Gugliotta; E Campanini; S Mangianti; Davide Gibellini; S Baravelli; Nicola Vianelli; Roberto M Lemoli; Sante Tura
Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
British journal of haematology 1998;100(1):207-18.
1997: Roberto M Lemoli; A Fortuna; Donatella Raspadori; MA Ventura; giovanni martinelli; Alessandro Gozzetti; Giuliana Leopardi; Marina Ratta; Michele Cavo; Sante Tura
Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma.
Leukemia & lymphoma 1997;26 Suppl 1():1-11.
1997: Maria Rosa Motta; S Mangianti; Simonetta Rizzi; Marina Ratta; E Campanini; A Fortuna; Miriam Fogli; Sante Tura; Roberto M Lemoli
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
Experimental hematology 1997;25(12):1261-9.
1997: Roberto M Lemoli; A Fortuna; Agostino Tafuri; Alexis Grande; Marilina Amabile; giovanni martinelli; Sergio Ferrari; Sante Tura
Interleukin-9 in human myeloid leukemia cells.
Leukemia & lymphoma 1997;26(5-6):563-73.
1997: F Bertolini; A de Vincentiis; L Lanata; Roberto M Lemoli; Rita Maccario; Ignazio Majolino; Luisa Ponchio; Damiano Rondelli; Antonio Tabilio; P Zanon; Sante Tura
Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.
Haematologica 1997;82(2):220-38.
1997: Roberto M Lemoli; Agostino Tafuri; A Fortuna; Maria Teresa Petrucci; Maria R Ricciardi; Lucia Catani; Damiano Rondelli; Miriam Fogli; Giuliana Leopardi; Cristina Ariola; Sante Tura
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
Blood 1997;89(4):1189-96.
1997: Maria Alessandra Santucci; Roberto M Lemoli; Sante Tura
Peripheral blood mobilization of hematopoietic stem cells: cytokine-mediated regulation of adhesive interactions within the hematopoietic microenvironment.
Acta haematologica 1997;97(1-2):90-6.
1996: Roberto M Lemoli; Gianantonio Rosti; Giuseppe Visani; Filippo Gherlinzoni; M C Miggiano; A Fortuna; Pier Luigi Zinzani; Sante Tura
Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3018-25.
1996: Roberto M Lemoli; Michele Cavo; A Fortuna
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Journal of hematotherapy 1996;5(4):339-49.
1996: F C Cappio; M Cavo; A DeVincentiis; L Lanuta; Roberto M Lemoli; Ignazio Majolino; Corrado Tarella; P Zanon; Sante Tura
Peripheral blood stem cell transplantation for the treatment of multiple myeloma: biological and clinical implications.
Haematologica 1996;81(4):356-75.
1996: Roberto M Lemoli; A Fortuna; Agostino Tafuri; Miriam Fogli; Marilina Amabile; Alexis Grande; Maria R Ricciardi; Maria Teresa Petrucci; Laura Bonsi; Gian Paolo Bagnara; Giuseppe Visani; giovanni martinelli; Sergio Ferrari; Sante Tura
Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.
Blood 1996;87(9):3852-9.
1996: Roberto M Lemoli; A Fortuna; Maria Rosa Motta; Simonetta Rizzi; V Giudice; A Nannetti; giovanni martinelli; Michele Cavo; Marilina Amabile; S Mangianti; Miriam Fogli; Roberto Conte; Sante Tura
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
Blood 1996;87(4):1625-34.
1996: Roberto M Lemoli; A Fortuna
C-kit ligand (SCF) in human multiple myeloma cells.
Leukemia & lymphoma 1996;20(5-6):457-64.
1996: Massimo Aglietta; A de Vincentiis; L Lanata; F Lanza; Roberto M Lemoli; G Menichella; A Tafuri; P Zanon; Sante Tura
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications.
Haematologica 1996;81(1):77-92.
1996: Roberto M Lemoli; A Fortuna; Miriam Fogli; Gianantonio Rosti; Filippo Gherlinzoni; Giuseppe Visani; Lucia Catani; Alessandro Gozzetti; Sante Tura
Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Acta haematologica 1996;95(3-4):164-70.
1995: Roberto M Lemoli; A Fortuna; Miriam Fogli; Filippo Gherlinzoni; Gianantonio Rosti; Lucia Catani; Alessandro Gozzetti; M C Miggiano; Sante Tura
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Experimental hematology 1995;23(14):1520-6.
1995: Roberto M Lemoli; Miriam Fogli; A Fortuna; Marilina Amabile; Patrizia Zucchini; Alexis Grande; giovanni martinelli; Giuseppe Visani; Sergio Ferrari; Sante Tura
Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells.
British journal of haematology 1995;91(2):319-26.
1995: C C Stella; M Cazzola; Paolo De Fabritiis; A de Vincentiis; ALESSANDRO MASSIMO GIANNI; F Lanza; F Lauria; Roberto M Lemoli; Corrado Tarella; P Zanon
CD34-positive cells: biology and clinical relevance.
Haematologica 1995;80(4):367-87.
1995: Roberto M Lemoli; Miriam Fogli; A Fortuna; Sante Tura
Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells.
Haematologica 1995;80(1):5-12.
1994: Roberto M Lemoli; A Fortuna; Alexis Grande; B Gamberi; Laura Bonsi; Miriam Fogli; Marilina Amabile; Michele Cavo; Sergio Ferrari; Sante Tura
Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells.
British journal of haematology 1994;88(4):760-9.
1994: giovanni martinelli; Roberto M Lemoli; P Farabegoli; A Zaccaria; Nicoletta Testoni; M Buzzi; Miriam Fogli; G Visani; P Tosi; Maria Rosa Motta
Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML). Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT).
Haematologica 1994;79(5):445-7.
1994: Roberto M Lemoli; A Fortuna; Miriam Fogli; Maria Rosa Motta; Simonetta Rizzi; C Benini; Sante Tura
Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Experimental hematology 1994;22(9):919-23.
1994: M C Miggiano; Filippo Gherlinzoni; Giuseppe Visani; A Belardinelli; Paolo Ricci; Gianantonio Rosti; Patrizio Mazza; Maria Rosa Motta; Simonetta Rizzi; Roberto M Lemoli
Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas: a single center experience.
Haematologica 1994;79(3):225-32.
1994: Roberto M Lemoli; Pier Luigi Tazzari; A Fortuna; Andrea Bolognesi; S C Gulati; Fiorenzo Stirpe; Sante Tura
Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins.
Bone marrow transplantation 1994;13(4):465-71.
1994: Giuseppe Visani; Patrizia Tosi; Pier Luigi Zinzani; Silvia Manfroi; Alfonso Zaccaria; Nicoletta Testoni; Roberto M Lemoli; Gianantonio Rosti; S Pelliconi; Sante Tura
FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case report.
British journal of haematology 1994;86(2):394-6.
1993: Roberto M Lemoli; Miriam Fogli; A Fortuna; Maria Rosa Motta; Simonetta Rizzi; C Benini; Sante Tura
Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1993;21(13):1668-72.
1993: Roberto M Lemoli
Characterization and selection of benign stem cells in chronic myeloid leukemia.
Haematologica 1993;78(6):393-400.
1993: Maria Rosa Motta; C Benini; Giuseppe Bandini; Filippo Gherlinzoni; M C Miggiano; E Calori; Roberto M Lemoli; Sante Tura
Autologous bone marrow transplantation with marrow cryopreserved for ten years.
Bone marrow transplantation 1993;12(2):177.
1992: Maria Giulia Battelli; A Abbondanza; Pier Luigi Tazzari; Andrea Bolognesi; Roberto M Lemoli; Fiorenzo Stirpe
T lymphocyte killing by a xanthine-oxidase-containing immunotoxin.
Cancer immunology, immunotherapy : CII 1992;35(6):421-5.
1991: Cristina Tassi; A Fortuna; Andrea Bontadini; Roberto M Lemoli; marco gobbi; Pier Luigi Tazzari
CD34 or S313 positive cells selection by avidin-biotin immunoadsorption.
Haematologica 1991;76 Suppl 1():41-3.
1990: Giuseppe Visani; Simonetta Rizzi; Patrizia Tosi; A Cenacchi; B Gamberi; Roberto M Lemoli; P Papadopulu; Sante Tura
In vitro effects of bisantrene on fresh clonogenic leukemia cells: a preliminary study on 15 cases.
Haematologica 1990;75(6):527-31.
1990: Giuseppe Visani; Roberto M Lemoli; Patrizia Tosi; F Verlicchi; B Gamberi; A R Cenacchi; R Colombini; Miriam Fogli; Domenico Russo; Elisa Zuffa
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma.
Blut 1990;60(5):287-90.
1990: Giuseppe Visani; A Dinota; Patrizia Tosi; F Verlicchi; Maria Rosa Motta; Simonetta Rizzi; R Colombini; A Cenacchi; Miriam Fogli; Roberto M Lemoli
Cryopreserved autologous bone marrow transplantation in patients with acute nonlymphoid leukemia: chemotherapy before harvesting is the main factor in delaying hematological recovery.
Cryobiology 1990;27(2):103-6.
1989: Giuseppe Visani; Patrizia Tosi; D Benfenati; R Colombini; A R Cenacchi; B Gamberi; Roberto M Lemoli; Sante Tura
[GM-CSF: its use in onco-hematologic diseases].
Haematologica 1989;74(5 Suppl):501-10.
1989: Roberto M Lemoli; Giuseppe Visani; marco gobbi; Simonetta Rizzi; A Dinota; Cristina Tassi; Patrizia Tosi; Piero Galieni; Michele Cavo; Sante Tura
Normal myeloid progenitors (CFU-GM) in multiple myeloma: a preliminary study in view of autologous BMT.
Bone marrow transplantation 1989;4(4):373-7.
1989: L Barbieri; A Dinota; marco gobbi; P L Tazzari; Simonetta Rizzi; Andrea Bontadini; Roberto M Lemoli; S Tura; Fiorenzo Stirpe
Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell-associated antigens: effects on target cells and on normal myeloid precursors (CFU-GM).
European journal of haematology 1989;42(3):238-45.
1989: Roberto M Lemoli; marco gobbi; Pier Luigi Tazzari; T C Tassi; A Dinota; Giuseppe Visani; G Grassi; P Mazza; Michele Cavo; Sante Tura
Bone marrow purging for multiple myeloma by avidin-biotin immunoadsorption.
Transplantation 1989;47(2):385-7.
1989: Sante Tura; Patrizio Mazza; Filippo Gherlinzoni; Pier Luigi Zinzani; G Poletti; Giuseppe Visani; Roberto M Lemoli; Michele Cavo; Piero Galieni; Cristina Tassi
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.
Cancer chemotherapy and pharmacology 1989;23(2):123-5.
1989: Giuseppe Visani; Roberto M Lemoli; Patrizia Tosi; A Dinota; Cristina Tassi; Miriam Fogli; Michele Cavo
In vitro growth of myeloma cells.
European journal of haematology. Supplementum 1989;51():43-6.
1988: Sante Tura; Patrizio Mazza; Filippo Gherlinzoni; Pier Luigi Zinzani; G Poletti; Giuseppe Visani; Roberto M Lemoli; G Bandini; Michele Cavo; Piero Galieni
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies.
Haematologica 1988;73(6):503-8.
1988: Giuseppe Visani; A Dinota; F Verlicchi; Giuseppe Bandini; Paolo Ricci; Maria Rosa Motta; Simonetta Rizzi; Roberto M Lemoli; C Poluzzi; Filippo Gherlinzoni
Autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma: comparison of different parameters in predicting the kinetics of haematological recovery.
Bone marrow transplantation 1988;3(6):599-605.
1988: Pier Luigi Tazzari; M Gobbi; Cristina Tassi; Roberto M Lemoli; A Dinota; Giuseppe Visani; Sante Tura
In situ staining of bromodeoxyuridine positive cells in normal and neoplastic colony-forming units grown on plasma clots.
Journal of immunological methods 1988;113(2):215-9.
1988: Giuseppe Visani; Roberto M Lemoli; A Dinota; Michele Cavo; M Gobbi; Sante Tura
Improvement of human myeloma stem cell growth in a liquid culture system supplemented with phytohemagglutinin.
International journal of cell cloning 1988;6(5):313-23.
1988: Giuseppe Visani; D Russo; Daniela Damiani; Simonetta Rizzi; Maria Rosa Motta; Roberto M Lemoli; C Poluzzi; Renato Fanin; Elisa Zuffa; P Tosi
Sensitivity of Ph 1 + CFU-GM to human recombinant interferon alpha and gamma alone and in combination.
Blut 1988;57(1):41-4.
1988: Roberto M Lemoli; Giuseppe Visani; P Tosi; P Mazza; Maria Rosa Motta; Simonetta Rizzi; P L Zinzani; C Poluzzi; Filippo Gherlinzoni; S Tura
Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM).
Haematologica 1988;73(3):195-200.
1988: Roberto M Lemoli; Giuseppe Visani; Maria Rosa Motta; Simonetta Rizzi; Paolo Ricci; Giuseppe Bandini; C Poluzzi; S Tura
Long-term cryopreservation of autologous bone marrow: analysis of granulocyte-macrophage progenitor (CFU-GM) viability in 31 samples stored more than 48 months.
Haematologica 1988;73(2):101-4.